Cargando…

Cardiovascular Effects of CAR T Cell Therapy: A Retrospective Study

BACKGROUND: Anti-CD19 chimeric antigen receptor (CAR) T cell therapy holds great promise in the treatment of patients with hematologic malignancies. A high occurrence of cardiac dysfunction has been noted in children treated with CAR T cell therapy. OBJECTIVES: The aim of this study was to define th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lefebvre, Bénédicte, Kang, Yu, Smith, Amanda M., Frey, Noelle V., Carver, Joseph R., Scherrer-Crosbie, Marielle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413146/ https://www.ncbi.nlm.nih.gov/pubmed/32776016 http://dx.doi.org/10.1016/j.jaccao.2020.04.012

Ejemplares similares

The Association of Metformin With Heart Failure in Patients With Diabetes Mellitus Receiving Anthracycline Chemotherapy
por: Onoue, Takeshi, et al.
Publicado: (2023)

Symptomatic Heart Failure in Acute Leukemia Patients Treated With Anthracyclines
por: Kang, Yu, et al.
Publicado: (2019)

Cardiovascular manifestations and treatment considerations in COVID-19
por: Kang, Yu, et al.
Publicado: (2020)

Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
por: Porter, David, et al.
Publicado: (2018)

Women with peripartum cardiomyopathy have normal ejection fraction, but abnormal systolic strain, during pregnancy
por: Tamrat, Ruth, et al.
Publicado: (2021)

Strain Imaging in Cardio-Oncology
por: Liu, Jennifer E., et al.
Publicado: (2020)

Phosphomimetic Modulation of eNOS Improves Myocardial Reperfusion and Mimics Cardiac Postconditioning in Mice
por: Pong, Terrence, et al.
Publicado: (2014)

Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies: JACC: CardioOncology State-of-the-Art Review
por: Parashar, Susmita, et al.
Publicado: (2023)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021)

The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018)

Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
por: Porter, D., et al.
Publicado: (2018)

CAR-T Cell Therapy
por: Ahmad, Aamir
Publicado: (2020)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022)

CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
por: Knochelmann, Hannah M., et al.
Publicado: (2018)

Case Report: Active tuberculosis infection in CAR T-cell recipients post CAR T-cell therapy: a retrospective case series
por: Zhang, Peiling, et al.
Publicado: (2023)

Seatbelts in CAR therapy: How Safe Are CARS?
por: Minagawa, Kentaro, et al.
Publicado: (2015)

CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy
por: Harrer, Dennis Christoph, et al.
Publicado: (2023)

CAR T Cell Therapy–Related Cardiovascular Outcomes and Management: Systemic Disease or Direct Cardiotoxicity?
por: Ghosh, Arjun K., et al.
Publicado: (2020)

Guidelines for measuring cardiac physiology in mice
por: Lindsey, Merry L., et al.
Publicado: (2018)

Collaboration during Crisis: A Novel Point-of-Care Ultrasound Alliance among Emergency Medicine, Internal Medicine, and Cardiology in the COVID-19 Era
por: Panebianco, Nova, et al.
Publicado: (2021)

Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy
por: Kilgour, Marisa K., et al.
Publicado: (2023)

CAR T Cell Therapy for Neuroblastoma
por: Richards, Rebecca M., et al.
Publicado: (2018)

Engineering switchable and programmable universal CARs for CAR T therapy
por: Liu, Delong, et al.
Publicado: (2019)

Ultrasound-Enhancing Agents and Associated Adverse Reactions: A Potential Connection to the COVID-19 Vaccines?
por: Soni, Meshal, et al.
Publicado: (2022)

Dynamic fine-tuning of CAR-T cell therapy
por: Trehin, Pierre V.M., et al.
Publicado: (2023)

Cytokines Are at the Heart of It: Cytokine Release Syndrome Underlies Cardiovascular Effects of CAR T Cell
por: Catino, Anna B.
Publicado: (2020)

Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
por: Martínez Bedoya, Darel, et al.
Publicado: (2021)

CAR T cell therapy becomes CHIC: “cytokine help intensified CAR” T cells
por: Thomas, Simone, et al.
Publicado: (2023)

Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCL
por: Jeyakumar, Nikeshan, et al.
Publicado: (2022)

China enters CAR-T cell therapy era
por: Cao, Xin, et al.
Publicado: (2021)

Challenges of Anti-Mesothelin CAR-T-Cell Therapy
por: Zhai, Xuejia, et al.
Publicado: (2023)

Donor T cells for CAR T cell therapy
por: Tang, Tiffany C. Y., et al.
Publicado: (2022)

Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
por: Albinger, Nawid, et al.
Publicado: (2021)

CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles’ Heel?
por: Ferreira, Leonardo M. R., et al.
Publicado: (2021)

CAR-T Cell Therapy: Mechanism, Management, and Mitigation of Inflammatory Toxicities
por: Fischer, Joseph W., et al.
Publicado: (2021)

Modelling CAR-T therapy in humanized mice
por: Wu, Yongxia, et al.
Publicado: (2019)

Engineering enhanced CAR T-cells for improved cancer therapy
por: Milone, Michael C., et al.
Publicado: (2021)

Artificial intelligence and imaging: Opportunities in cardio-oncology
por: Madan, Nidhi, et al.
Publicado: (2022)

The Race of CAR Therapies: CAR-NK Cells for Fighting B-Cell Hematological Cancers
por: Herrera, Lara, et al.
Publicado: (2021)

How to Manage Patients With Cardiac Implantable Electronic Devices Undergoing Radiation Therapy
por: Fradley, Michael G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c6hfu69grpnictshrqnlqgfc1b